-----BEGIN PRIVACY-ENHANCED MESSAGE----- Proc-Type: 2001,MIC-CLEAR Originator-Name: webmaster@www.sec.gov Originator-Key-Asymmetric: MFgwCgYEVQgBAQICAf8DSgAwRwJAW2sNKK9AVtBzYZmr6aGjlWyK3XmZv3dTINen TWSM7vrzLADbmYQaionwg5sDW3P6oaM5D3tdezXMm7z1T+B+twIDAQAB MIC-Info: RSA-MD5,RSA, SK5AiEdHfP98ufKFWTUv6fDMRQeHlLOZOON3QydFQeeKfULvoF+0dxPcR3HRO4PQ ltPeaZoUsxZoBeFE4CnuJA== 0001064901-08-000001.txt : 20080814 0001064901-08-000001.hdr.sgml : 20080814 20080814211354 ACCESSION NUMBER: 0001064901-08-000001 CONFORMED SUBMISSION TYPE: 5 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20080630 FILED AS OF DATE: 20080814 DATE AS OF CHANGE: 20080814 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: INTEGRATED BIOPHARMA INC CENTRAL INDEX KEY: 0001016504 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 133035216 STATE OF INCORPORATION: DE FISCAL YEAR END: 0630 BUSINESS ADDRESS: STREET 1: 201 ROUTE 22 CITY: HILLSIDE STATE: NJ ZIP: 07205 BUSINESS PHONE: 9739260816 MAIL ADDRESS: STREET 1: 201 ROUTE 22 CITY: HILLSIDE STATE: NJ ZIP: 07205 FORMER COMPANY: FORMER CONFORMED NAME: INTEGRATED HEALTH TECHNOLOGIES INC DATE OF NAME CHANGE: 20020912 FORMER COMPANY: FORMER CONFORMED NAME: CHEM INTERNATIONAL INC DATE OF NAME CHANGE: 19960716 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: KAY CHRISTINA CENTRAL INDEX KEY: 0001064901 FILING VALUES: FORM TYPE: 5 SEC ACT: 1934 Act SEC FILE NUMBER: 001-31668 FILM NUMBER: 081021143 BUSINESS ADDRESS: STREET 1: 201 ROUTE 22 CITY: HILLSIDE STATE: NJ ZIP: 07205 BUSINESS PHONE: 9739260816 5 1 inb5_christinakayex.xml X0303 5 2008-06-30 0 0 1 0001016504 INTEGRATED BIOPHARMA INC INBP 0001064901 KAY CHRISTINA 1 1 0 0 Vice President Restricted Stock Unit 2007-11-16 4 A 0 70000 0 A 1030800 D Common Stock 2008-08-12 4 C 0 66666 1.50 A 1030800 D Common Stock 2008-08-12 4 C 0 150000 .50 A 1030800 D Common Stock 2008-08-12 4 C 0 100000 .75 A 1030800 D Common Stock 2008-08-12 4 C 0 100000 .33 A 1030800 D Stock Option 3.05 2007-11-16 4 A 0 30000 0 A 2017-11-02 Common Stock 30000 205333 D Stock Option 1.50 2008-08-12 4 C 0 66666 0 D 1998-10-07 2008-10-07 Common Stock 66666 205333 D Stock Option .50 2008-08-12 4 C 0 150000 0 D 1999-12-01 2009-12-01 Common Stock 150000 205333 D Stock Option .75 2008-08-12 4 C 0 100000 0 D 2000-12-19 2010-12-19 Common Stock 100000 205333 D Stock Option .33 2008-08-12 4 C 0 100000 0 D 2002-10-11 2012-10-11 Common Stock 100000 205333 D On November 16, 2007, the Reporting Person was granted 70,000 Restricted Stock Units as compensation for serving as an officer and director of the Issuer. Each Restricted Stock Unit consists of a right to the issuance of one share of Common Stock. The Restricted Stock Units are subject to a three-year vesting period. None of the Restricted Stock Units are included in the amount of securities beneficially owned following the reported transaction in column 5, as none of the Restricted Stock Units will vest in the next 60 days. Represents the amount of securities beneficially owned by the Reporting Person as of the date hereof. On August 12, 2008, the Reporting Person exercised a total of 416,666 options to purchase common stock of the Issuer. The options were originally granted to the Reporting Person for her service as an officer and director of the Issuer. On November 16, 2007, the Reporting Person was granted a stock option to purchase 30,000 shares of Common Stock at an exercise price of $3.05 per share as compensation for serving as an officer and director of the Issuer. These stock options are subject to a three-year vesting period, with an initial annual vesting date of November 2, 2008. None of these stock options are included in the amount of derivative securities beneficially owned following the reported transaction in column 9, as none of the stock options will vest in the next 60 days. /s/ CHRISTINA KAY 2008-08-14 -----END PRIVACY-ENHANCED MESSAGE-----